![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Improvement of hyperorality after using selective serotonin reuptake inhibitor in hypoxic brain damage |
Heewon Bae, Min Ju Kang |
J Geriatr Neurol. 2023;2(1):29-31. Published online February 15, 2023 DOI: https://doi.org/10.53991/jgn.2022.00115 |
Improvement of hyperorality after using selective serotonin reuptake inhibitor in hypoxic brain damage Improvement of Post Stroke Echolalia after Using Selective Serotonin Reuptake Inhibitors On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor Perinatal Selective Serotonin Reuptake Inhibitor Exposure: Impact on Brain Development and Neural Plasticity Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor Comment: Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with α-[ 14 C]methyl- l -tryptophan 2 2Abbreviations: 5-HT, serotonin, 5-hydroxytryptamine; α-[14C]MTrp, α-[14C]methyl-l-tryptophan; SSRI, selective serotonin reuptake inhibitor; and α-[14C]M5HT, α-[14C]methyl-5-HT. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development Remission of Chronic Severe Selective Serotonin-Reuptake Inhibitor/Selective Norepinephrine-Reuptake Inhibitor Refractory Depression Following Adjunctive Aripiprazole A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder |